HotSpot Therapeutics

HotSpot Therapeutics Presents Preclinical Data on Oral Small Molecule IRF5 Inhibitor HST‑2011 at ACR Convergence 2026

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target natural…